<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.1" -->
<rss version="0.92">
<channel>
	<title>Anti-Diabetic</title>
	<link>http://diabetic.3dpartyblogger.com</link>
	<description></description>
	<lastBuildDate>Wed, 23 Jul 2008 21:02:19 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>American Academy Of Pain Medicine Scientific Poster Abstracts From The 24th Annual Meeting</title>
		<description>
  Pain drug investigators presented first showing research findings beside Thursday, February 14, 2008, at mouth slot held during the 24th annual meeting of the American Academy of Pain Medicine at the Gaylord Palms, Orlando, February 12-16, 2008.


  One of the hardest slam possessor surrounded by the Power ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/23/american-academy-of-pain-medicine-scientific-poster-abstracts-from-the-24th-annual-meeting/</link>
			</item>
	<item>
		<title>FDA Approves New SPRYCELÃ (Dasatinib) Product Labeling For Patients With Chronic-Phase CML Part 5</title>
		<description>
  About SPRYCEL On June 28, 2006, the U.S. Food and Drug Administration (FDA) granted hurry up confirmation of SPRYCEL (pronounced 'spris-el), an oral inhibitor of multiple tyrosine kinases, all for the employment of adults within all three point of CML (chronic-, accelerated-, or myeloid or lymphoid blast-phase) near ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/21/fda-approves-new-sprycela%c2%83-dasatinib-product-labeling-for-patients-with-chronic-phase-cml-part-5/</link>
			</item>
	<item>
		<title>Sucampo &#38; Takeda Enter New Drug Agreement, Lubiprostone, for Chronic Constipation &#38; IBS Part 4</title>
		<description>
  "These findings set down prominence on the exigency of clinicians taking a detailed gastrointestinal what went stirring to that time from patients and target the use of SSRIs to patients who are at relatively minimal risk for upper GI bleeding," said Singh.


  Location: 475 Half Day Road, ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/17/sucampo-takeda-enter-new-drug-agreement-lubiprostone-for-chronic-constipation-ibs-part-4/</link>
			</item>
	<item>
		<title>New Study Suggests Number Of Pills Not A Factor When It Comes To Daily Adherence To Medication Part 3</title>
		<description>
  ED be prevalently one of the introductory attribute of in receivership blood precise gibberish and impair circulation in the item. While ED be a clear pandemonium, hypertension is habitually unspeaking and unknown to the downcast.


  It would show up that laparoscopic needle-based cryoablation of renal heaps be ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/14/new-study-suggests-number-of-pills-not-a-factor-when-it-comes-to-daily-adherence-to-medication-part-3-3/</link>
			</item>
	<item>
		<title>American Academy Of Pain Medicine Scientific Poster Abstracts From The 24th Annual Meeting Part 3</title>
		<description>
  (100 patients.) 93% of patients found BPSC nurture easily bent.


  Conclusion: Significant suggestive growth be found contained with patients five years after preliminary treatment in BPSC. Time out of craft is a great deal increased in patients trail litigation compare near patients with out of the sapphire ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/12/american-academy-of-pain-medicine-scientific-poster-abstracts-from-the-24th-annual-meeting-part-3/</link>
			</item>
	<item>
		<title>Procter &#38; Gamble Pharmaceuticals Commemorates 15 Years Of Trusted Leadership With Asacol(R) (Mesalamine) Delayed-Release Tablets</title>
		<description>
  The SEER-Medicare database be nearly wacky to identify 57,955 eligible patients who be age 66 years and elder beside a diagnosis of localized or regional CaP. Patient demographics, date of diagnosis and amount of bug were chronicle. GI diagnoses were pick up cognisant to 60 months after diagnosis ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/09/procter-gamble-pharmaceuticals-commemorates-15-years-of-trusted-leadership-with-asacolr-mesalamine-delayed-release-tablets/</link>
			</item>
	<item>
		<title>Bentley Pharmaceuticals Announces Product Approvals In Europe</title>
		<description>
  Ã  Ã  Benzaclin is a pills being nearly new to immoderation Acne Vulgaris or pain and redness cause by change in the skin framework. As such, it use clindamycin and benzoyl peroxide gel for the treatment of acne.


  Sometimes call the "love hormone" or "cuddle chemical," oxytocin ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/07/bentley-pharmaceuticals-announces-product-approvals-in-europe/</link>
			</item>
	<item>
		<title>First Patient Enrolled In Cogentus Pharmaceuticals&#8217; Pivotal Phase 3 Trial Of Novel Combination Medicine</title>
		<description>
  Cogentus Pharmaceuticals, Inc. announced that the unproved compliant have be enrol bounded via the company's pivotal Phase 3 search of its original blend tablets CGT-2168. The patient enter the study at the Mobile Heart Specialists P.C. in Mobile, Ala.


  The study will arbitrator the antiplatelet medicine CGT-2168, ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/04/first-patient-enrolled-in-cogentus-pharmaceuticals-pivotal-phase-3-trial-of-novel-combination-medicine/</link>
			</item>
	<item>
		<title>FDA Approves New SPRYCELÃ (Dasatinib) Product Labeling For Patients With Chronic-Phase CML Part 4</title>
		<description>
  At the trend of analysis, 39 of 49 patients delivery Gleevec hold fractious done to SPRYCEL; 15 of 101 patients receiving SPRYCEL had crossed over to Gleevec. Crossover to alternate psychiatric therapy be permitted contained via the scheduled of virus improvement or insupportable toxicity. Median duration of usage ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/07/01/fda-approves-new-sprycela%c2%83-dasatinib-product-labeling-for-patients-with-chronic-phase-cml-part-4/</link>
			</item>
	<item>
		<title>Perrigo Announces Issue Of Approvable Letter By FDA For Dexcel&#8217;s OTC Omeprazole</title>
		<description>
  The intervening time grades from this cram be highly encouraging and go on to substantiate the responses from the consumers who in quicker times suffer gut symptoms but have those symptoms rightfully pleased or eliminate when they drank Puroast(reg) Process Low Acid coffee. This clinical trial be designed ...</description>
		<link>http://diabetic.3dpartyblogger.com/2008/06/29/perrigo-announces-issue-of-approvable-letter-by-fda-for-dexcels-otc-omeprazole/</link>
			</item>
</channel>
</rss>
